V. Harvey

1.7k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

V. Harvey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, V. Harvey has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in V. Harvey's work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). V. Harvey is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). V. Harvey collaborates with scholars based in New Zealand, Australia and United Kingdom. V. Harvey's co-authors include Andreas Schneeweiß, Roberto Hegg, Javier Cortés, Tamas Hickish, Alexandru Eniu, G. Ross, Christoph Tausch, Jayantha Ratnayake, Virginia McNally and Stephen Chia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

V. Harvey

20 papers receiving 1.1k citations

Hit Papers

Pertuzumab plus trastuzumab in combination with standard ... 2013 2026 2017 2021 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
    2013 774 citations Andreas Schneeweiß, Stephen Chia et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Harvey New Zealand 11 833 520 263 205 128 22 1.1k
Sirkku Jyrkkiö Finland 15 538 0.6× 275 0.5× 351 1.3× 180 0.9× 90 0.7× 48 1.1k
Stella Dolci Belgium 12 847 1.0× 488 0.9× 250 1.0× 118 0.6× 43 0.3× 27 1.1k
I. Craig Henderson United States 7 903 1.1× 520 1.0× 223 0.8× 112 0.5× 49 0.4× 7 1.1k
Brian Magee United Kingdom 7 400 0.5× 792 1.5× 384 1.5× 214 1.0× 243 1.9× 9 1.2k
Antoine Avril France 11 523 0.6× 679 1.3× 150 0.6× 138 0.7× 192 1.5× 13 980
A. Goldhirsch Italy 15 537 0.6× 382 0.7× 88 0.3× 143 0.7× 54 0.4× 39 825
EP Mamounas United States 16 767 0.9× 967 1.9× 273 1.0× 200 1.0× 219 1.7× 49 1.3k
É. Luporsi France 19 545 0.7× 255 0.5× 69 0.3× 232 1.1× 292 2.3× 66 1.0k
Sherko Küemmel Germany 18 686 0.8× 554 1.1× 428 1.6× 331 1.6× 74 0.6× 78 1.3k
N. Malamos Greece 15 649 0.8× 343 0.7× 73 0.3× 212 1.0× 41 0.3× 32 864

Countries citing papers authored by V. Harvey

Since Specialization
Citations

This map shows the geographic impact of V. Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Harvey more than expected).

Fields of papers citing papers by V. Harvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Harvey. The network helps show where V. Harvey may publish in the future.

Co-authorship network of co-authors of V. Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of V. Harvey. A scholar is included among the top collaborators of V. Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Harvey. V. Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elwood, Mark, Sandar Tin Tin, Richard Marshall, et al.. (2018). A New Predictive Model for Breast Cancer Survival in New Zealand: Development, Internal and External Validation, and Comparison With the Nottingham Prognostic Index. Journal of Global Oncology. 4(Supplement 2). 227s–227s. 2 indexed citations
2.
Schneeweiß, Andreas, Stephen Chia, Tamas Hickish, et al.. (2013). Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Annals of Oncology. 24(9). 2278–2284. 774 indexed citations breakdown →
3.
Ribi, Karin, Julie Aldridge, Kelly‐Anne Phillips, et al.. (2012). Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British Journal of Cancer. 106(10). 1618–1625. 17 indexed citations
4.
5.
Sasidharan, Rita & V. Harvey. (2010). Pregnancy and breast cancer. Obstetric Medicine. 3(2). 54–58. 8 indexed citations
6.
Green, M. D., Prudence A. Francis, Val Gebski, et al.. (2009). Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer. Annals of Oncology. 20(11). 1813–1817. 51 indexed citations
7.
Duric, V., Prudence A. Francis, Arlene Chan, et al.. (2007). Preferences for adjuvant chemotherapy (ACT) in early breast cancer: The benefits needed to make extended treatment with docetaxel, doxorubicin, and CMF worthwhile. Journal of Clinical Oncology. 25(18_suppl). 6528–6528. 2 indexed citations
8.
Harvey, V. & Nancy E. McMurray. (1997). Students' Perceptions of Nursing: Their Relationship to Attrition. Journal of Nursing Education. 36(8). 383–389. 42 indexed citations
9.
Ahmed, Mohamed I., et al.. (1992). In vitro Buffering Capacity of Residual Peritoneal Dialysate Fluid: Implications for Peritoneal Dialysis Therapy. Artificial Organs. 16(4). 416–418. 22 indexed citations
10.
Harvey, V., et al.. (1991). Reduction of carboplatin induced emesis by ondansetron. British Journal of Cancer. 63(6). 942–944. 17 indexed citations
11.
Cebon, Jonathan, et al.. (1990). Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer. British Journal of Cancer. 61(1). 133–136. 2 indexed citations
12.
13.
Levi, John A., Damien Thomson, V. Harvey, et al.. (1990). Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.. Journal of Clinical Oncology. 8(1). 27–32. 15 indexed citations
14.
Holdaway, I. M., et al.. (1988). Zoladex Treatment of Symptomatic Prostatic Carcinoma. American Journal of Clinical Oncology. 11. S123–126. 4 indexed citations
15.
Levi, John A., Damien Thomson, Martin Tattersall, et al.. (1988). A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.. Journal of Clinical Oncology. 6(7). 1154–1160. 48 indexed citations
16.
Holdaway, I. M., H.K. Ibbertson, Michael Croxson, et al.. (1988). Treatment of metastatic prostate carcinoma with the depot LRH analog zoladex. The Prostate. 12(2). 119–127. 3 indexed citations
17.
Holdaway, I.M., H.K. Ibbertson, Michael Croxson, et al.. (1988). Treatment of Metastatic Prostate Carcinoma With the Depot LRH Analog Zoladex. The Journal of Urology. 140(6). 1602–1602.
18.
Ibbertson, H.K., et al.. (1987). Zoladex treatment of symptomatic prostatic carcinoma. European Journal of Cancer and Clinical Oncology. 23(8). 1241–1241.
19.
20.
Hines, George L. & V. Harvey. (1985). The post endarterectomy carotid bruit. Evaluation by Duplex scan.. PubMed. 51(10). 570–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sirkku Jyrkkiö Breakdown of academic impact, for papers by Stella Dolci Breakdown of academic impact, for papers by I. Craig Henderson Breakdown of academic impact, for papers by Brian Magee Breakdown of academic impact, for papers by Antoine Avril Breakdown of academic impact, for papers by A. Goldhirsch Breakdown of academic impact, for papers by EP Mamounas Breakdown of academic impact, for papers by É. Luporsi Breakdown of academic impact, for papers by Sherko Küemmel Breakdown of academic impact, for papers by N. Malamos
Rankless by CCL
2026